Diaz Alejandro A, Young Thomas P, Maselli Diego J, Martinez Carlos H, Gill Ritu, Nardelli Pietro, Wang Wei, Kinney Gregory L, Hokanson John E, Washko George R, San Jose Estepar Raul
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Chest. 2017 Jun;151(6):1255-1262. doi: 10.1016/j.chest.2016.11.024. Epub 2016 Nov 24.
Bronchiectasis is frequent in smokers with COPD; however, there are only limited data on objective assessments of this process. The objective was to assess bronchovascular morphology, calculate the ratio of the diameters of bronchial lumen and adjacent artery (BA ratio), and identify those measurements able to discriminate bronchiectasis.
We collected quantitative CT (QCT) measures of BA ratios, peak wall attenuation, wall thickness (WT), wall area, and wall area percent (WA%) at matched fourth through sixth airway generations in 21 ever smokers with bronchiectasis (cases) and 21 never-smoking control patients (control airways). In cases, measurements were collected at both bronchiectatic and nonbronchiectatic airways. Logistic analysis and the area under receiver operating characteristic curve (AUC) were used to assess the predictive ability of QCT measurements for bronchiectasis.
The whole-lung and fourth through sixth airway generation BA ratio, WT, and WA% were significantly greater in bronchiectasis cases than control patients. The AUCs for the BA ratio to predict bronchiectasis ranged from 0.90 (whole lung) to 0.79 (fourth-generation). AUCs for WT and WA% ranged from 0.72 to 0.75 and from 0.71 to 0.75. The artery diameters but not bronchial diameters were smaller in bronchiectatic than both nonbronchiectatic and control airways (P < .01 for both).
Smoking-related increases in the BA ratio appear to be driven by reductions in vascular caliber. QCT measures of BA ratio, WT, and WA% may be useful to objectively identify and quantify bronchiectasis in smokers.
ClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.
支气管扩张在慢性阻塞性肺疾病(COPD)吸烟者中很常见;然而,关于这一过程客观评估的数据有限。目的是评估支气管血管形态,计算支气管腔与相邻动脉直径之比(BA比),并确定能够鉴别支气管扩张的测量指标。
我们收集了21例有支气管扩张的既往吸烟者(病例组)和21例从不吸烟的对照患者(对照气道)在匹配的第四至第六级气道的BA比、峰值壁衰减、壁厚(WT)、壁面积和壁面积百分比(WA%)的定量CT(QCT)测量值。在病例组中,在支气管扩张气道和非支气管扩张气道均进行测量。采用逻辑分析和受试者操作特征曲线下面积(AUC)评估QCT测量对支气管扩张的预测能力。
支气管扩张病例组的全肺及第四至第六级气道的BA比、WT和WA%显著高于对照患者。BA比预测支气管扩张的AUC范围为0.90(全肺)至0.79(第四级)。WT和WA%的AUC范围为0.72至0.75和0.71至0.75。支气管扩张气道的动脉直径小于非支气管扩张气道和对照气道(两者P <.01),但支气管直径无差异。
吸烟相关的BA比增加似乎是由血管管径减小所致。QCT测量的BA比、WT和WA%可能有助于客观识别和量化吸烟者的支气管扩张。
ClinicalTrials.gov;编号:NCT00608764;网址:www.clinicaltrials.gov。